What Gene Sequencer is Roche (RHHBY) Aiming to Buy? (ILMN) (GENE)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Roche Prepared to Pay $66/Share for Illumina (ILMN) - Reports
December 20, 2012 6:57 AM ESTIllumina, Inc. (NASDAQ: ILMN) is on watch Thursday following reports from L'Agefi that Roche has agreed to pay $66 per share for the company although a deal has not been finalized.
Illumina rejected a $51 per share bid from Roche in April 2012. Roche... More
Roche (RHHBY) May Use Cash to Reduce Debt, Make Acquisitions - CFO Hippe
December 20, 2012 6:11 AM ESTRoche (OTCBB: RHHBY) plans to make acquisitions in the $6 billion to $7 billion range, according to CFO Alan Hippe.
The firm is targeting technologies, including gene sequencing, and it might buy smaller, complimentary firms.
Roche plans to reduce debt to... More
